Mesa Laboratories Statistics
Share Statistics
Mesa Laboratories has 5.43M shares outstanding. The number of shares has increased by 0.69% in one year.
| Shares Outstanding | 5.43M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.41% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 5.21M |
| Failed to Deliver (FTD) Shares | 50 |
| FTD / Avg. Volume | 0.13% |
Short Selling Information
The latest short interest is 155.20K, so 2.86% of the outstanding shares have been sold short.
| Short Interest | 155.20K |
| Short % of Shares Out | 2.86% |
| Short % of Float | 2.98% |
| Short Ratio (days to cover) | 4.19 |
Valuation Ratios
The PE ratio is -2.37 and the forward PE ratio is 15.29.
| PE Ratio | -2.37 |
| Forward PE | 15.29 |
| PS Ratio | 2.79 |
| Forward PS | 2.8 |
| PB Ratio | 4.15 |
| P/FCF Ratio | 14.51 |
| PEG Ratio | n/a |
Enterprise Valuation
Mesa Laboratories Inc. has an Enterprise Value (EV) of 1.07B.
| EV / Earnings | -4.2 |
| EV / Sales | 4.94 |
| EV / EBITDA | -4.48 |
| EV / EBIT | -3.92 |
| EV / FCF | 25.67 |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 1.52.
| Current Ratio | 2.47 |
| Quick Ratio | 1.73 |
| Debt / Equity | 1.52 |
| Total Debt / Capitalization | 60.39 |
| Cash Flow / Debt | 0.2 |
| Interest Coverage | -47.76 |
Financial Efficiency
Return on equity (ROE) is -1.75% and return on capital (ROIC) is -66.62%.
| Return on Equity (ROE) | -1.75% |
| Return on Assets (ROA) | -0.57% |
| Return on Capital (ROIC) | -66.62% |
| Revenue Per Employee | 293.73K |
| Profits Per Employee | -345.44K |
| Employee Count | 736 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.54 |
Taxes
| Income Tax | -21.40M |
| Effective Tax Rate | 0.08 |
Stock Price Statistics
The stock price has increased by 37.15% in the last 52 weeks. The beta is 0.86, so Mesa Laboratories 's price volatility has been higher than the market average.
| Beta | 0.86 |
| 52-Week Price Change | 37.15% |
| 50-Day Moving Average | 123.54 |
| 200-Day Moving Average | 115.91 |
| Relative Strength Index (RSI) | 49.73 |
| Average Volume (20 Days) | 38.91K |
Income Statement
In the last 12 months, Mesa Laboratories had revenue of 216.19M and earned -254.25M in profits. Earnings per share was -47.2.
| Revenue | 216.19M |
| Gross Profit | 133.25M |
| Operating Income | -272.07M |
| Net Income | -254.25M |
| EBITDA | -238.38M |
| EBIT | -272.07M |
| Earnings Per Share (EPS) | -47.2 |
Balance Sheet
The company has 28.21M in cash and 231.30M in debt, giving a net cash position of -203.08M.
| Cash & Cash Equivalents | 28.21M |
| Total Debt | 231.30M |
| Net Cash | -203.08M |
| Retained Earnings | -183.49M |
| Total Assets | 454.10M |
| Working Capital | -45.25M |
Cash Flow
In the last 12 months, operating cash flow was 44.13M and capital expenditures -2.57M, giving a free cash flow of 41.57M.
| Operating Cash Flow | 44.13M |
| Capital Expenditures | -2.57M |
| Free Cash Flow | 41.57M |
| FCF Per Share | 7.72 |
Margins
Gross margin is 61.64%, with operating and profit margins of -125.85% and -117.6%.
| Gross Margin | 61.64% |
| Operating Margin | -125.85% |
| Pretax Margin | -127.5% |
| Profit Margin | -117.6% |
| EBITDA Margin | -110.26% |
| EBIT Margin | -125.85% |
| FCF Margin | 19.23% |
Dividends & Yields
MLAB pays an annual dividend of $0.64, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | -1.4% |
| Earnings Yield | -36.09% |
| FCF Yield | 5.85% |
Analyst Forecast
The average price target for MLAB is $140, which is 7% higher than the current price. The consensus rating is "Buy".
| Price Target | $140 |
| Price Target Difference | 7% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -0.45 |
| Piotroski F-Score | 5 |